Our meeting is the place to learn about the latest international research across specialties in peripheral neuropathy. As the largest peripheral nerve meeting globally, it is the premier venue to connect with your peers.

Industry Sponsored Symposia

We thank our 2024 Annual Partners for their support of the meeting. This meeting would not be possible without their ongoing annual support. We invite you to attend their symposia programs, held Sunday – Tuesday of the meeting. Please indicate your interest in these programs when registering for PNS 2024. The PNS will not be providing lunch outside of these sponsored events. If you have already registered for the meeting and wish to attend one of these programs, please contact info@PNSociety.com to have it added to your existing registration.

PeerVoice Lunch Symposium: Prioritizing Patient-Centered Care for ATTR: Expert Perspectives on the Evolution of Data and Decision-Making

PeerVoice Lunch Symposium: Prioritizing Patient-Centered Care for ATTR: Expert Perspectives on the Evolution of Data and Decision-Making

Sunday 23 June 2024 | 13.00 - 14.00

This symposium is organized by PeerVoice and supported by an educational grant from AstraZeneca. 

 

Program Details

Chair:
Isabel Conceição, MD, ULS Santa Maria, Centro Académico de Medicina de Lisboa, Lisbon, Portugal

Faculty:
Isabel Conceição, MD, ULS Santa Maria, Centro Académico de Medicina de Lisboa, Lisbon, Portugal

Anasheh Halabi, MD, PhD, UCLA, Los Angeles, CA, USA

Michelle Mezei, BSc(Pharm), MDCM, FRCPC, University of British Columbia, Vancouver General Hospital, Vancouver, British Columbia, Canada University of British Columbia

Welcome and Introduction
13.00 – 13.03
Isabel Conceição, MD, ULS Santa Maria, Centro Académico de Medicina de Lisboa, Lisbon, Portugal

The Realities of ATTR: Recognizing Opportunities to Change the Patient Journey
13.03 – 13.10
Anasheh Halabi, MD, PhD, UCLA, Los Angeles, CA, USA

Suspicion and Recognition of ATTR: Improving Timely Diagnosis and Differentiation Between Phenotypes
13.10 – 13.20
All Faculty

Insights on the Innovation in ATTR: Appreciating the Data and Its Impact on Decision-Making
13.20 – 13.35
All Faculty

Patient-First Approaches to ATTR: Providing Comprehensive and Collaborative Care
13.35 – 13.45
All Faculty

ATTR, Asked and Answered: Panel Discussion of Audience Questions
13.45 – 14.00
All Faculty

Sanofi Lunch Symposium: Spotlight on CIDP: Evolving Perspectives on Disease and Treatment

Sanofi Lunch Symposium: Spotlight on CIDP: Evolving Perspectives on Disease and Treatment

Sunday, 23 June 2024 | 13.00 - 14.00

 

Program Details

Chair:
Luis Querol, MD, PhD, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Faculty:
Kathrin Doppler, MD, University Hospital Würzburg, Würzburg, Deutschland

Richard Lewis, MD, Cedars-Sinai, Los Angeles, CA, USA

Luis Querol, MD, PhD, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Welcome and Introduction: Evolution of CIDP Treatment
13.00 – 13.10
Luis Querol, MD, PhD, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Understanding Heterogeneity and Prognosis of CIDP
13.10 – 13.25
Richard Lewis, MD, Cedars-Sinai, Los Angeles, CA, USA

Emerging Topics in CIDP Pathophysiology and Biomarkers
13.25 – 13.35
Kathrin Doppler, MD, University Hospital Würzburg, Würzburg, Deutschland

Panel Discussion and Q&A: Redefining Art and Science in CIDP Treatment: From Now to the Future
13.35 – 13.55
All Faculty

Summary and Meeting Close
13.55 – 14.00
Luis Querol, MD, PhD,Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

argenx Lunch Symposium: Our Evolving Understanding of CIDP: Pathophysiology, Current Treatment Landscape, and the Rationale for Targeting FcRn

argenx Lunch Symposium: Our Evolving Understanding of CIDP: Pathophysiology, Current Treatment Landscape, and the Rationale for Targeting FcRn

Monday, 24 June 2024 | 13.15 - 14.15

 

Program Details

Faculty:
Jeffrey Allen, MD, University of Minnesota, Minneapolis, MN, USA

Thomas Harbo, MD, PhD, Aarhus University, Aarhus, Denmark

Karissa Gable, MD, Duke University, Durham, NC, USA

Welcome
13.15-13.20

CIDP Disease Overview and Current Treatment Landscape
13.20 – 13.30
Thomas Harbo, MD, PhD, Aarhus University, Aarhus, Denmark

Potential Role of IgG in the Pathophysiology of CIDP and Rationale for FcRn Targeting
13.30 – 13.45
Karissa Gable, MD, Duke University, Durham, NC, USA

Managing Progression
13.45 – 14.05
Jeffrey Allen, MD, University of Minnesota, Minneapolis, MN, USA

Q&A
14.05-14.15

Takeda Lunch Symposium: Diagnostic Dilemmas: An Interactive Journey through CIDP

Takeda Lunch Symposium: Diagnostic Dilemmas: An Interactive Journey through CIDP

Monday, 24 June 2024 | 13.15 - 14.15

 

Program Details

Chair:
Johannes Jakobsen, MD, DMSci, Copenhagen University Hospital, Copenhagen, Denmark

Faculty:
Vera Bril, FRCPC, MD, University of Toronto, Toronto, Canada

Johannes Jakobsen, MD, DMSci, Copenhagen University Hospital, Copenhagen, Denmark

Claudia Sommer, MD, University Hospital Würzburg, Würzburg, Deutschland

Introductions
13.15 – 13.20
Johannes Jakobsen, MD, DMSci, Copenhagen University Hospital, Copenhagen, Denmark

Understanding CIDP and the Clinical Landscape
13.20 – 13.30
Johannes Jakobsen, MD, DMSci, Copenhagen University Hospital, Copenhagen, Denmark

Diagnostic Dilemmas: An Interactive Journey through CIDP
13.30 – 14.05
All Faculty

Q&A
14.05 – 14.10
All Faculty

Summary and Close
14.10 – 14.15
Johannes Jakobsen, MD, DMSci, Copenhagen University Hospital, Copenhagen, Denmark

argenx Breakfast Symposium: Unravel the Mystery of MMN

argenx Breakfast Symposium: Unravel the Mystery of MMN

Tuesday, 25 June 2024 | 07.00-8.00

 

Program Details

Chair:
Richard Lewis, MD, Cedars-Sinai, Los Angeles, CA, USA

Faculty:
Katie Beadon, MD, MASc, FRCPC, University of British Columbia – St. Paul’s Hospital, Vancouver, Canada

Hans Katzberg, MD, FRCPC, MSc, University of Toronto, Toronto, Canada

Richard Lewis, MD, Cedars-Sinai, Los Angeles, CA, USA

Welcome
7.00-7.05

Gathering Clues: Addressing Unmet Needs in MMN
7.00 – 7.15
Richard Lewis, MD, Cedars-Sinai, Los Angeles, CA, USA

Assembling the Puzzle: Challenges in MMN Diagnosis and Treatment
7.15 – 7.30
Katie Beadon, MD, MASc, FRCPC, University of British Columbia – St. Paul’s Hospital, Vancouver, Canada

Unraveling the MMN Mystery: Current Management of MMN and Future Therapeutic Advancements
7.30 – 7.50
Hans Katzberg, MD, FRCPC, MSc, University of Toronto, Toronto, Canada

Q&A and Closing Remarks
7.50-8.00

Annexon Biosciences Lunch Symposium: Breaking New Ground in the GBS Treatment Landscape

Annexon Biosciences Lunch Symposium: Breaking New Ground in the GBS Treatment Landscape

Tuesday, 25 June 2024 | 13.15 - 14.15

 

Program Details

Chair:
David Cornblath, MD, Baltimore, MD, USA

Faculty:
Jeffrey Allen, MD, University of Minnesota, Minneapolis, MN, USA

Lisa Butler, GBS|CIDP FI, Conshohocken, PA, USA

David Cornblath, MD, Baltimore, MD, USA

Bart Jacobs, MD, PhD, Erasmus MC, Rotterdam, Netherlands

Luis Querol, MD, PhD, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Welcome & Moderated Overview
13.15 – 13.23
David Cornblath, MD, Baltimore, MD, USA

GBS Revisited
13.23 – 13.33
Bart Jacobs, MD, PhD,Erasmus MC, Rotterdam, Netherlands

Role of Complement and Biomarkers in GBS Pathogenesis
13.33 – 13.43
Luis Querol, MD, PhD, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

GBS Treatment: Can We Do Better?
13.43 – 13.58
Jeffrey Allen, MD, University of Minnesota, Minneapolis, MN, USA

Q&A
13.58 – 14.13
All Faculty

Closing
14.13-14.15
David Cornblath, MD, Baltimore, MD, USA

CSL Behring Lunch Symposium: Advancing CIDP Care: Integrating Diagnostic Techniques with Safe and Effective Immunoglobulin Therapies

CSL Behring Lunch Symposium: Advancing CIDP Care: Integrating Diagnostic Techniques with Safe and Effective Immunoglobulin Therapies

Tuesday, 25 June 2024 | 13.15 - 14.15

 

Program Details

Chair:
Hans Katzberg, MD, FRCPC, MSc, University of Toronto, Toronto, Canada

Faculty:
Hans Katzberg, MD, FRCPC, MSc, University of Toronto, Toronto, Canada

Simon Rinaldi, MRCP(Neuro), PhD, University of Oxford, Oxford, UK

Lisa Hobson-Webb, MD, Duke University, Durham, NC, USA

Donna Hartlen, Patient Advocate

Connecting the Pathophysiology of CIDP to the Mechanisms of Action of Immunoglobulin Therapy
13.17 – 13.32
Simon Rinaldi, MRCP(Neuro), PhD, University of Oxford, Oxford, UK

Nerve Ultrasound in CIDP
13.32 – 13.47
Lisa Hobson-Webb, MD, Duke University, Durham, NC, USA

A Focus on Immunoglobulin Safety and the Patient Experience in the Management of CIDP
13.47 – 14.07
Donna Hartlen, Patient Advocate
Hans Katzberg, MD, FRCPC, MSc, University of Toronto, Toronto, Canada